Know Cancer

or
forgot password

Retrospective Study :Describe the Changes of the Disease in Many Cases Likely to Aggravate.


N/A
18 Years
N/A
Not Enrolling
Female
Congenital Myasthenic Syndrome

Thank you

Trial Information

Retrospective Study :Describe the Changes of the Disease in Many Cases Likely to Aggravate.


The aim of this study is to better understand the action of hormonal factors that are
presumably incriminated for the fluctuation of the disease. The investigators would also
like to better adress the issues of women with Congenital Myasthenic Syndrome, who desire a
pregnancy : the possibility of decompensation, the problems that can arise during the course
of the childbearing, the risk of foetal malformations.

Inclusion Criteria


Inclusion criteria:

- Adult women

- Congenital myastenic syndrome genetically confirmed or with clinical compatible and
electrophysiological evidence

- Written consent

Exclusion Criteria:

- Neurological or general pathology occurs significantly with the initiation and
conduct of a pregnancy.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Principal Investigator

Laurent SERVAIS, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

institut myologie

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

2010-A00495-34

NCT ID:

NCT01474980

Start Date:

January 2010

Completion Date:

October 2011

Related Keywords:

  • Congenital Myasthenic Syndrome
  • Congenital Myasthenic Syndrome
  • Pregnancy
  • Outcome
  • Lambert-Eaton Myasthenic Syndrome
  • Myasthenic Syndromes, Congenital

Name

Location